498 related articles for article (PubMed ID: 8832894)
1. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.
Denissenko MF; Pao A; Tang M; Pfeifer GP
Science; 1996 Oct; 274(5286):430-2. PubMed ID: 8832894
[TBL] [Abstract][Full Text] [Related]
2. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
[TBL] [Abstract][Full Text] [Related]
3. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
[TBL] [Abstract][Full Text] [Related]
4. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
Hu W; Feng Z; Tang MS
Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
[TBL] [Abstract][Full Text] [Related]
5. Formation of benzo[a]pyrene diol epoxide-DNA adducts at specific guanines within K-ras and p53 gene sequences: stable isotope-labeling mass spectrometry approach.
Tretyakova N; Matter B; Jones R; Shallop A
Biochemistry; 2002 Jul; 41(30):9535-44. PubMed ID: 12135376
[TBL] [Abstract][Full Text] [Related]
6. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
[TBL] [Abstract][Full Text] [Related]
7. Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer.
Feng Z; Hu W; Chen JX; Pao A; Li H; Rom W; Hung MC; Tang MS
J Natl Cancer Inst; 2002 Oct; 94(20):1527-36. PubMed ID: 12381705
[TBL] [Abstract][Full Text] [Related]
8. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers.
Denissenko MF; Pao A; Pfeifer GP; Tang M
Oncogene; 1998 Mar; 16(10):1241-7. PubMed ID: 9546425
[TBL] [Abstract][Full Text] [Related]
9. Mutagenicity of benzo[a]pyrene-deoxyadenosine adducts in a sequence context derived from the p53 gene.
Khalili H; Zhang FJ; Harvey RG; Dipple A
Mutat Res; 2000 Feb; 465(1-2):39-44. PubMed ID: 10708967
[TBL] [Abstract][Full Text] [Related]
10. TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.
Kucab JE; van Steeg H; Luijten M; Schmeiser HH; White PA; Phillips DH; Arlt VM
Mutat Res; 2015 Mar; 773():48-62. PubMed ID: 25847421
[TBL] [Abstract][Full Text] [Related]
11. The influence of cytosine methylation on the chemoselectivity of benzo[a]pyrene diol epoxide-oligonucleotide adducts determined using nanoLC/MS/MS.
Glick J; Xiong W; Lin Y; Noronha AM; Wilds CJ; Vouros P
J Mass Spectrom; 2009 Aug; 44(8):1241-8. PubMed ID: 19536795
[TBL] [Abstract][Full Text] [Related]
12. 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene.
Feng Z; Hu W; Rom WN; Beland FA; Tang MS
Carcinogenesis; 2002 Oct; 23(10):1721-7. PubMed ID: 12376482
[TBL] [Abstract][Full Text] [Related]
13. Base damage, local sequence context and TP53 mutation hotspots: a molecular dynamics study of benzo[a]pyrene induced DNA distortion and mutability.
Menzies GE; Reed SH; Brancale A; Lewis PD
Nucleic Acids Res; 2015 Oct; 43(19):9133-46. PubMed ID: 26400171
[TBL] [Abstract][Full Text] [Related]
14. Formation of diastereomeric benzo[a]pyrene diol epoxide-guanine adducts in p53 gene-derived DNA sequences.
Matter B; Wang G; Jones R; Tretyakova N
Chem Res Toxicol; 2004 Jun; 17(6):731-41. PubMed ID: 15206894
[TBL] [Abstract][Full Text] [Related]
15. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons.
Smith LE; Denissenko MF; Bennett WP; Li H; Amin S; Tang M; Pfeifer GP
J Natl Cancer Inst; 2000 May; 92(10):803-11. PubMed ID: 10814675
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
[TBL] [Abstract][Full Text] [Related]
17. Use of UvrABC nuclease to quantify benzo[a]pyrene diol epoxide-DNA adduct formation at methylated versus unmethylated CpG sites in the p53 gene.
Tang MS; Zheng JB; Denissenko MF; Pfeifer GP; Zheng Y
Carcinogenesis; 1999 Jun; 20(6):1085-9. PubMed ID: 10357792
[TBL] [Abstract][Full Text] [Related]
18. Differential c-myc expression profiles in normal human bronchial epithelial cells following treatment with benzo[a]pyrene, benzo[a]pyrene-4,5 epoxide, and benzo[a]pyrene-7,8-9,10 diol epoxide.
Fields WR; Desiderio JG; Leonard RM; Burger EE; Brown BG; Doolittle DJ
Mol Carcinog; 2004 Jun; 40(2):79-89. PubMed ID: 15170813
[TBL] [Abstract][Full Text] [Related]
19. Mutagenic potential of benzo[a]pyrene-derived DNA adducts positioned in codon 273 of the human P53 gene.
Dong H; Bonala RR; Suzuki N; Johnson F; Grollman AP; Shibutani S
Biochemistry; 2004 Dec; 43(50):15922-8. PubMed ID: 15595848
[TBL] [Abstract][Full Text] [Related]
20. Effect of CpG methylation at different sequence context on acrolein- and BPDE-DNA binding and mutagenesis.
Wang HT; Weng MW; Chen WC; Yobin M; Pan J; Chung FL; Wu XR; Rom W; Tang MS
Carcinogenesis; 2013 Jan; 34(1):220-7. PubMed ID: 23042304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]